Trial intelligence / Profile preview

DAYLIGHT: Daridorexant in Elderly Insomnia Patients with Hypertension

jRCTs071260069Recruiting

Sponsor
Shionogi & Co., Ltd.
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of daridorexant in Insomnia, sponsored by Shionogi & Co., Ltd. Primary endpoint: Change in Insomnia Severity Index at Visit 4. Started Aug 2026; status: recruiting.

02

Drugs

daridorexant
03

Conditions

Insomnia

Beyond the preview

Go deeper on jRCTs071260069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs071260069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call